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ABSTRACT
The DNA damage-binding protein 2 (DDB2) is
an adapter protein that can direct a modular Cul4-
DDB1-RING E3 Ligase complex to sites of ultraviolet
light-induced DNA damage to ubiquitinate
substrates during nucleotide excision repair. The
DDB2 transcript is ultraviolet-inducible; therefore,
its regulation is likely important for its function.
Curiously, the DDB2 mRNA is reportedly short-
lived, but the transcript does not contain any
previously characterized cis-acting determinants of
mRNA stability in its 30 untranslated region (30UTR).
Here, we used a tetracycline regulated d2EGFP
reporter construct containing specific 30UTR se-
quences from DDB2 to identify novel cis-acting
elements that regulate mRNA stability. Synthetic
30UTRs corresponding to sequences as short as 25
nucleotides from the central region of the 30UTR of
DDB2 were sufficient to accelerate decay of the
heterologous reporter mRNA. Conversely, these
same 30UTRs led to more rapid induction of the
reporter mRNA, export of the message to the cyto-
plasm and the subsequent accumulation of the
encoded reporter protein, indicating that this
newly identified cis-acting element affects tran-
scriptional and post-transciptional processes.
These results provide clear evidence that nuclear
and cytoplasmic processing of the DDB2 mRNA is
inextricably linked.
INTRODUCTION
Damage-speciﬁc DNA binding protein 2 (DDB2) was ori-
ginally identiﬁed in association with DDB1 as part of an
ultraviolet (UV)-induced protein complex with DNA
damage-binding activity (1,2). Mutations in the DDB2
gene are associated with xeroderma pigmentosum group
E, a rare genetic disorder characterized by DNA repair
defects, sun-sensitivity and a predisposition to skin
cancer. Fibroblasts derived from xeroderma pigmentosum
group E patients have modest UV sensitivity with a
measurable defect in the global genomic subpathway of
nucleotide excision repair (GG-NER) (3–5). Although its
precise role in GG-NER remains somewhat enigmatic, it is
thought that DDB2 facilitates GG-NER through early
damage recognition (6–9). It is now recognized that the
DDB1 protein is part of a modular Cul4-DDB1-RING E3
Ligase complex (CRL4) (2,10,11) and that this complex
can be directed to a wide array of substrates through
adapter proteins like DDB2 (CRL4DDB2) (2). Thus,
DDB2 can direct CRL4 to UV lesions where it can
locally ubiquitinate a variety of proteins to affect local
chromatin structure and facilitate the assembly of a
GG-NER complex (2,11–15). In addition to its role in
GG-NER, CRL4DDB2 can also regulate cell cycle progres-
sion and senescence through the ubiquitination of other
substrates (16–24). These various functions of DDB2
indicate that this protein plays several critical anti-neo-
plastic roles; therefore, understanding its regulation is
critical to understand its role in GG-NER and cancer.
DDB2 expression and activity is tightly controlled
through a variety of transcriptional and post-translational
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mechanisms (11,25–29). Transcription of the DDB2 gene
is regulated, in large part, by the p53 tumour suppressor, a
transcription factor that positively regulates the expression
of genes encoding proteins involved in DNA repair, cell
cycle checkpoints and apoptosis (27,30). Recently, we used
a temperature sensitive variant of p53 that permits rapid
reversible regulation of p53 activity to monitor the induc-
tion and subsequent decay of p53-induced gene expression
using oligonucleotide microarrays (29). The p53 transcrip-
tional response was readily reversible, and it was
dominated by short-lived mRNAs, including DDB2
mRNA (29). Although most of the unstable p53-induced
mRNAs contained a variety of sequence motifs associated
with rapid turnover of mRNAs, the DDB2 mRNA did not
contain any consensus destabilizing elements in its 30UTR
(29). Therefore, the primary sequence of the DDB2
mRNA did not predict in an obvious way its rapid
decay following transient p53 activation.
Here, we report the characterization of the 30UTR of
DDB2 using tetracycline-regulated heterologous
d2EGFP-30UTR reporter constructs, expressing a variant
of green ﬂourescent protein (GFP). Using this system, we
were able to identify a short region within the 30UTR of
DDB2 that affects transcription and decay of the reporter
transcript. Our results suggest that this 30UTR sequence is
recognized co-transcriptionally linking transcriptional and
post-transcriptional regulatory pathways. The present
work suggests that the 30UTR of DDB2 plays an import-
ant role in regulating DDB2 expression and that this likely
contributes to its anti-neoplastic activity. Furthermore,
similar sequences were identiﬁed in the 30UTRs of unre-
lated transcripts, suggesting that expression of their
encoded proteins may be regulated similarly.
MATERIALS AND METHODS
Cell culture and complementary DNA synthesis
HeLa Tet-Off cells were purchased from Clontech
Laboratories (Mountain View, CA), whereas HT29-tsp53
cells were obtained from Mats Ljungman (University of
Michigan) (31). Cells were grown in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal calf serum
(Thermo Fisher Scientiﬁc, Waltham, MA) and 200 mg/ml
G418 antibiotic (Sigma-Aldrich, St. Louis, MO) at 37C in
a humidiﬁed atmosphere with 5% CO2.
Generation of d2EGFP 30UTR reporter constructs
The 30UTR of DDB2 and deﬁned regions of this 30UTR
were cloned using a reverse transcriptase polymerase chain
reaction (RT-PCR)-based strategy with complementary
DNA (cDNA) derived from colorectal cancer cells
(HT29-tsp53 cells) (29). Brieﬂy, cells were detached with
trypsin, and harvested, and total RNA was collected from
cells using the RNeasy RNA isolation kit (QIAGEN).
Five micrograms of RNA were reverse-transcribed using
oligo-dT primers and the First Strand cDNA Synthesis
Kit (MBI Fermentas, Burlington, ON). Primers contain-
ing either EcoRI (50) or XbaI (30) linkers were used to
amplify speciﬁc regions of the 30UTR of DDB2 by
RT-PCR (Supplementary Table S1). A variety of smaller
synthetic 30UTRs corresponding to mutant versions
spanning nucleotides 149–198 of the DDB2 30UTR were
synthesized as complementary oligonucleotides (Sigma-
Aldrich Canada Ltd, Oakville, ON, Canada) with the
same 50 and 30 linker sequences (Supplementary Table
S2). These oligonucleotides were subsequently annealed
in vitro in Oligo Annealing Buffer (Promega, Madison,
WI) according to manufacturer’s instructions.
Heterologous d2EGFP-DDB2 30UTR reporter con-
structs were generated by subcloning the corresponding
dsDNA into EcoRI and XbaI restriction sites located
between the d2EGFP open reading frame and the SV40
polyadenylation signal of the pTRE-d2EGFP vector
(PT3228-5, Clontech laboratories, Mountain View, CA)
(32). The identity of all constructs was conﬁrmed by
DNA sequencing (StemCore Laboratories, Ottawa, ON).
Transfections and ﬂuorescence-activated cell sorting
HeLa Tet-Off cells or HEK293 Tet-On cells were
seeded at 50% conﬂuence and 24 h later were transfected
with pTRE-d2EGFP or heterologous reporter constructs
using GeneJuice Transfection Reagent (EMD Chemicals,
Gibbstown, NJ). In transient transfection experiments,
doxycycline was added 24 h following transfection. To
generate stable HeLa Tet-Off-derived d2EGFP-express-
ing populations, d2EGFP positive cells were identiﬁed
by ﬂuorescence-activated cell sorting (FACS) using a
DakoCytomation MoFlo ﬂow cytometer (Dako,
Denmark). The ﬂuorescent cells were expanded and
further enriched by two additional rounds of FACS
yielding a highly enriched d2EGFP-positive population.
To generate stable HEK293 Tet-On-derived d2EGFP-
expressing populations, FACS was performed similarly
except that doxycycline was added 24 h before each sort
to express d2EGFP.
For quantitative analysis of green ﬂuorescence,
d2EGFP-positive cells were detached with trypsin,
washed and collected in phosphate buffered saline
(PBS). Flow cytometry was carried out using a Beckman
Coulter Epics XL ﬂow cytometer (Beckman Coulter,
Mississauga, ON). The d2EGFP ﬂuorescence was
analysed using FCS Express 3.0 software package (De
Nova Software, Los Angeles, CA).
Quantitative RT-PCR
The cDNAs of interest were generated as described earlier
in the text. Quantitative RT-PCR (qRT-PCR) analysis
was performed using the Sybr green ﬂuorescent DNA
stain (Invitrogen, Carlsbad, CA) and the LightCycler 2
thermo cycler machine with Light-Cycler software
version 3 (Roche Diagnostics, Switzerland). The expres-
sion of the d2EGFP mRNA was determined using the
following primer pairs: CGACGGCAACTACAAGACC
and CCATCATCCTGCTCCTCCAC. Expression of
d2EGFP mRNA was normalized to the expression of
b-actin (GGGCATGGGTCAGAAGGAT and GTGGC
CATCTCTTGCTCGA) and/or Glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) (AACAGCGACACCC
ACTCCTC and GGAGGGGAGATTCAGTGTGGT)
mRNA levels, with similar results.
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Polysome isolation
Polysomes were isolated as previously described (33).
Brieﬂy, cells from two 15-cm diameter plates were
incubated in 100 mg/ml cycloheximide (CHX) for 3min
at 37C. Cells were washed with ice-cold PBS containing
CHX, scraped and collected by centrifugation at 200 g.
The cells were lysed in 500 ml of ice-cold polysome lysis
buffer [15mM Tris–HCl (ph 7.4), 15mM MgCl2, 300mM
NaCl, 1% (v/v) Triton X-100, CHX (0.1mg/ml), Rnasin
(100U/ml)], transferred to microcentrifuge tubes and
incubated on ice for 10min. Nuclei were pelleted at
5000 rpm for 5min at 4C. Supernatants were transferred
to fresh tubes while the nuclear fractions were stored at
80C. The non-nuclear fractions were centrifuged for
5min at 14 000 rpm at 4C to remove debris. These super-
natants were transferred to fresh tubes, and they were
stored at 80C. Lysates containing equal units of
optical density at 254 nm were placed onto linear sucrose
gradients (10–50%) and centrifuged at 39 000 rpm for
90min at 4C. Fractions from each gradient were sequen-
tially collected from the top of the gradient using a
Teledyne ISCO R1/R2 fraction collector coupled with a
UA6 Absorbance detector (Teledyne, Lincoln, NE).
Fractions were stored at 80C. RNA from each
fraction, including nuclear pellets, was isolated by
phenol-chloroform extraction followed by ethanol precipi-
tation. Equal volumes of RNA were used to generate
cDNA and analysed by quantitative RT-PCR, as
described earlier in the text.
Immunoblot analysis
Immunoblotting was performed as previously described
(34). Brieﬂy, 20 mg of total protein derived from whole-cell
lysates were resolved by gel electrophoresis
using NuPAGE 3–8% gradient polyacrylamide gels
(Invitrogen). Proteins were transferred to Hybond-C
nitrocellulose (GE Healthcare, Baie d’Urfe´, QC), and
blots were stained with Ponceau S Red (5mg/ml
Ponceau S Red, 2% glacial acetic acid) to visualize total
transferred proteins. Blots were then blocked in TBSMT
[50mM Tris, 150mM NaCl (pH 7.6) (TBS), 5% non-fat
milk powder, 0.05% Tween 20]. Proteins were detected
using HRP-conjugated antibodies against GFP (clone
B2, 1:200, Santa Cruz) diluted in TBSM (TBS, 0.5%
nonfat milk powder) and were visualized using
SuperSignal West Pico Chemiluminescent Substrate
(Thermo Fisher Scientiﬁc) in combination with X-ray
ﬁlm (Kodak, Rochester, NY). The anti-GFP antibodies
were removed using Restore Western Blot Stripping
Buffer (Thermo Fisher Scientiﬁc) and reprobed with
anti-b-actin (clone AC-74, 1:4000, Sigma-Aldrich
Canada Ltd, Oakville, ON) followed by horse radish
peroxidase (HRP)–conjugated goat-anti-mouse secondary
antibodies and visualized similarly.
Statistical analysis
Statistical analysis was performed using the Prism 3.02
software package (GraphPad, San Diego, CA). The stat-
istical comparison of means was performed by one-way
analysis of variance (ANOVA) followed by Tukey’s
multple comparisons test. Statistical comparison of time
course experiments was performed by two-way ANOVA.
Unless stated otherwise, statistical signiﬁcance was
inferred using a threshold of P 0.05.
RESULTS
The central region from 30UTR of DDB2 acts in cis to
accelerate the decay of heterologous RNA
The DDB2 mRNA was reported to have a short half-life;
yet, the 30UTR contained no identiﬁable destabilizing
elements (29); therefore, we sought to identify novel
cis-acting elements in its 30UTR. To do this, we ﬁrst
subcloned various regions of the 30UTR of DDB2 into
the pTRE-d2EGFP plasmid between the d2EGFP open
reading frame and the polyadenylation sequence
(Figure 1A). These constructs placed the heterologous
reporter cDNA under tetracycline-repressible control in
HeLa Tet-Off cells (29). Transient transfection of HeLa
Tet-Off cells with the d2EGFP-UTR1–343 construct (con-
taining nucleotides 1–343 of the 30UTR of DDB2) led to
readily detectable d2EGFP mRNA that could be depleted
signiﬁcantly more rapidly than vector control-encoded
d2EGFP mRNA lacking this 30UTR sequence following
addition of doxycycline (Figure 1B).
To facilitate quantitative analysis of d2EGFP mRNA
and protein expression, we generated stable pools of
d2EGFP-expressing cells by transfecting HeLa Tet-Off
cells with these pTRE-d2EGFP constructs. The trans-
fected cells were subjected to three rounds of FACS and
expansion of the d2EGFP-positive cells to generate homo-
geneous stable populations expressing the d2EGFP gene
(Figure 1C). Addition of doxycycline to vector control
and d2EGFP-UTR1–343 cells led to a reduction in
d2EGFP mRNA expression with the 30UTR of DDB2
accelerating the decay of the reporter mRNA
(Figure 1D). Importantly, the rate of decay of these
mRNAs was comparable with that observed in transient
transfection experiments with the same constructs
(compare Figure 1B and D). Therefore, the 30UTR of
DDB2 functions in cis to regulate mRNA decay.
To localize cis-acting determinants of mRNA stability
in the 30UTR of the DDB2 transcript, the decay of
d2EGFP mRNA was monitored in other pooled cell
lines expressing heterologous d2EGFP mRNAs with dif-
ferent fragments of the 30UTR of DDB2. The addition of
doxycycline led to decreased expression of all reporter
genes tested (Figure 1E). Although the d2EGFP-
UTR1–164 and d2EGFP-UTR200–363 mRNAs decayed at
a rate similar to vector controls, the d2EGFP-UTR1–198,
d2EGFP-UTR150–198 and d2EGFP-UTR150–363 mRNAs
decayed signiﬁcantly faster that the control mRNA, and
his was similar to the mRNAs containing the full-length
30UTR of DDB2 (Figure 1E). These unstable mRNAs
were similarly short-lived in transient transfection experi-
ments (Figure 1F and data not shown). Therefore, a 49-nt
sequence common to these three heterologous reporter
mRNAs, corresponding to nucleotides 150–198 was sufﬁ-
cient to accelerate the decay of the reporter construct.
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Discordance between d2EGFP mRNA and protein levels
The d2EGFP protein is a fusion of eGFP with a
C-terminal PEST sequence derived from ornithine decarb-
oxylase; therefore, this ﬂuorescent protein is turned over
rapidly in a proteasome-dependent manner with a half-life
of 2 h (32). We chose this short-lived reporter protein
because unstable proteins require ongoing translation;
therefore, their levels were expected to correlate with the
amount of template mRNA available for translation.
However, the relationship between mRNA and protein
levels was more complex than anticipated.
Flow cytometric analysis of d2EGFP expression
indicated that the addition of doxycycline to vector
control or d2EGFP-UTR1–343 cells resulted in a decrease
in green ﬂuorescence without any remarkable qualitative
differences between cell lines (Figure 2A). Quantitative
analysis of d2EGFP, d2EGFP-UTR1–343 and d2EGFP-
UTR150–198 cells indicated that ﬂuorescence was highest
in d2EGFP-UTR1–343 cells, despite the instability of the
encoding mRNA (Figure 2B). In time course experiments,
green ﬂuorescence decreased marginally faster in the
d2EGFP-UTR1–343 and d2EGFP-UTR150–198 cells
compared with control cells (Figure 2C). The initial dif-
ference in d2EGFP expression and the similar rate of
decrease in d2EGFP expression was conﬁrmed by
immunoblot analysis (Figure 2D). Although the
d2EGFP expressed from short-lived mRNAs disappeared
more rapidly in the presence of doxycycline (Figure 2C),
the large difference in mRNA expression (Figure 1B and
D–F) was not quantitatively reﬂected by the small differ-
ence in d2EGFP protein expression. This disparity
between protein and mRNA expression did not result
from differences in the rate of d2EGFP protein turnover
because the d2EGFP protein expressed from these vectors
exhibited similar half-lives in the presence of CHX
(Figure 2C). Taken together, the 30UTR of DDB2 had a
dramatic effect on d2EGFP mRNA decay with a much
smaller effect on the expression of the protein.
To address the disparity between mRNA and protein
levels, similar biological experiments were performed
except that cytoplasmic RNA was isolated and separated
by sucrose gradient sedimentation to capture ribosome-
associated RNAs (polysomes). For reference, a represen-
tative OD260 sedimentation proﬁle is presented in
Figure 3A. The expression of the d2EGFP and actin
mRNAs was highest in fraction 4, regardless of the
30UTR present in the reporter construct, suggesting that
all of these mRNAs were translated at a similar rate
(Figure 3B). Addition of doxycycline led to a decrease in
d2EGFP expression; however, the distribution of remain-
ing d2EGFP transcripts across these fractions remained
largely unchanged (Figure 3B–C). Quantitative analysis
indicated that there was a signiﬁcant decrease in
d2EGFP expression in polysomes (fractions 3–5) in all
cell lines (Figure 3D, P< 0.001, single sample t-test). A
similar decrease in d2EGFP mRNA expression was
detected in the cytoplasmic fraction collected before
sucrose-gradient sedimentation (Figure 3D). This modest
Figure 1. The 30UTR of DDB2 confers instability to a heterologous reporter gene. (A) Schematic representation of the pTRE-d2EGFP vector used
to generate 30UTR reporter constructs. The location of the tetracycline response element (TRE), minimal cytomegalovirus promoter (CMV), EGFP
with a C-terminal PEST sequence (d2EGFP), 30UTR cloning site and the polyadenylation signal are indicated. (B) HeLa Tet-Off cells were
transfected with the pTRE-d2EGFP vector or vectors containing a 30UTR corresponding to the indicated nucleotides from the 30UTR of DDB2.
In (B) and (F), doxycycline (1 mg/ml) was added 24 h after transfection and total RNA was collected at the indicated times to monitor loss of
d2EGFP expression by qRT-PCR. (C) Stable pools of d2EGFP positive cells were generated through multiple rounds of ﬂuorescence activated cell
sorting. (D and E) In all, 1 mg/ml of doxycycline was added to stable cell lines expression d2EGFP with the indicated 30UTR sequence. At the
indicated time, total RNA was collected for qRT-PCR analysis of d2EGFP expression. Each value in (B), (D), (E) and (F) represents the mean
(±SEM) determined in several independent experiments. The asterisk and double asterisk indicate the curve is signiﬁcantly different from the vector
control as determined by two-way ANOVA at P< 0.05 and P< 0.0001, respectively.
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difference in the amount of cytoplasmic and polysome-
associated d2EGFP mRNA among cell lines correlated
with the small differences in d2EGFP protein expression,
reported in Figure 2.
Remarkably, the control d2EGFP mRNA expression
was signiﬁcantly higher than the d2EGFP-UTR1–343 and
d2EGFP-UTR150–198 mRNAs in the nuclear RNA
fraction collected before polysome fractionation, and
this was comparable with d2EGFP mRNA in total
cellular RNA (Figure 3D). In contrast, the unstable
d2EGFP-UTR1–343 and d2EGFP-UTR150–198 transcripts
disappeared as rapidly from this pool of RNA as they
did from the polysome and cytoplasmic fractions
(Figure 3D). Therefore, the highly stable d2EGFP
mRNA encoded by the control vector resides primarily
in the nucleus and does not contribute to nascent transla-
tion, explaining the initial disparity detected between
d2EGFP mRNA and protein levels. The persistence of
the control mRNA in the nucleus indicates that this tran-
script is not degraded efﬁciently in the nucleus nor is it
exported efﬁciently to the cytoplasm. Conversely, our
results suggest that sequences within the 150–198 region
of the 30UTR of DDB2 affect the export of the heterol-
ogous mRNAs and/or its degradation in the nucleus.
The induction of d2EGFP
The potential effect of 30UTR sequences on nuclear export
motivated us to re-express d2EGFP by washing out doxy-
cycline. We hypothesized that differences in the rate of
mRNA export could profoundly inﬂuence d2EGFP
protein without greatly affecting mRNA expression.
Vector control, d2EGFP-UTR1–343 and d2EGFP-
UTR150–198 cells were treated with a low concentration
of doxycycline for 48 h to block reporter gene expression,
and then cells were thoroughly washed in PBS, and fresh
doxycycline-free media was replaced. The induction of
d2EGFP was apparent within 4 h following the removal
of doxycycline in d2EGFP-UTR150–198 and d2EGFP-
UTR1–343-expressing cells by ﬂow cytometry, whereas re-
expression of d2EGFP was delayed in vector control cells
(Figure 4A and B). The d2EGFP-UTR150–198 cells
recovered d2EGFP protein to pretreatment levels fastest,
restoring a normal ﬂow cytometric histogram within 16 h
(Figure 4A and B). Similar results were obtained through
immunoblot analysis (Supplementary Figure S1).
Unexpectedly, d2EGFP mRNA levels were also induced
faster in d2EGFP-UTR1–343 and d2EGFP-UTR150–198
compared with vector control cells, indicating that the
DDB2 derived 30UTRs inﬂuence d2EGFP mRNA synthe-
sis (Figure 4C). The more rapid recovery of d2EGFP
protein but not mRNA in the d2EGFP-UTR150–198
compared with the d2EGFP-UTR1–343 cells suggests that
this small RNA sequence is more effective at stimulating
reporter expression post-transcriptionally. Therefore, the
UTR150–198 sequence facilitates the recovery of reporter
gene expression, whereas other sequences in the 30UTR
of DDB2 likely have opposing effects on RNA metabol-
ism as well.
To ensure that these effects were not unique to this
particular cell line, HEK293 Tet-On cells were
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transfected with these heterologous constructs, and
d2EGFP positive cells were isolated by FACS. Addition
of doxycycline, in these cell lines, led to increased expres-
sion of d2EGFP. Once again, the UTR150–198-expressing
cells accumulated d2EGFP protein more rapidly
(Figure 5A, B and C). Taken together, nucleotides
150–198 from the 30UTR of DDB2 positively inﬂuence
reporter protein expression through a combination of
increased synthesis, export and/or translation of the
reporter mRNAs.
Inverted repeat and U-rich sequences in the 30UTR
of DDB2
The most obvious feature within the 49 nt sequence was a
7-nt inverted repeat sequence with a 6-nt intervening
sequence, corresponding to nucleotides 175–194 of the
30UTR of DDB2 (Figure 6A). To determine whether this
inverted repeat sequence may be essential for accelerated
mRNA decay, stable cell lines were generated expressing a
heterologous d2EGFP mRNA with the 175–194 30UTR
(Figure 6A). The d2EGFP-UTR175–194 reporter mRNA
decayed as rapidly as the d2EGFP-UTR150–198 transcript
(Figure 6B). Similarly, the d2EGFP-UTR175–194 mRNA
was unstable in transiently transfected HeLa Tet-Off
cells (Figure 6B). Therefore, the inverted repeat sequence
was not essential for accelerated decay of this mRNA, and
the minimal destabilizing region falls within a 25-nt region
corresponding to nucleotides 150–174.
The region immediately to the 50 side of the inverted
repeat was rich in uridine (8 of 13 residues) and was
devoid of cytosine (Figure 6A). We similarly generated a
synthetic 30UTR containing the 162–174 sequence
(Figure 6A). The resulting heterologous d2EGFP-
UTR162–174 mRNA was signiﬁcantly more stable than
either the d2EGFP-UTR150–198 or the d2EGFP-
UTR175–194 mRNAs in both stable cell lines and
transiently transfected HeLa Tet-Off cells (Figure 6B
and C). Taken together, the inverted repeat sequence
(nucleotides 175–194) is dispensable for accelerated
mRNA decay while the adjacent U-rich region
(nucleotides 162–174) appears to be important for rapid
turnover.
Next, we sought to determine whether the induction of
reporter gene expression or subcellular localization of
the reporter mRNAs was affected in the d2EGFP-
UTR162–174 and d2EGFP-UTR175–194 cell lines.
Reporter gene expression recovered more rapidly at the
protein and mRNA level in the d2EGFP-UTR175–194
Figure 3. Subcellular localization of d2EGFP mRNA. HeLa Tet-Off-derived cells were treated with either 0 or 1 mg/ml of doxycycline (shaded and
open bars, respectively) to inhibit reporter gene expression and 4 h later these cells were collected. Total cellular, nuclear, cytoplasmic and polysomal
RNA fractions were isolated. (A) A representative sucrose gradient sedimentation proﬁle of the polysome preparation is provided for reference.
Polysomal mRNAs are contained in fractions 3–5, as indicated. (B) The relative expression of d2EGFP and beta actin across these gradient fractions
was determined by qRT-PCR. RNA levels are expressed relative to total input RNA level from no doxycycline control samples. (C) For comparison,
the expression of d2EGFP mRNA following doxycycline treatment in (B) is expressed as a percentage of its respective total input RNA. (D) The
expression of d2EGFP in several distinct cellular compartments was determined. Each value represents the mean (±SEM) from several independent
experiments. The asterisk indicates the value is signiﬁcantly different from controls in the presence of doxycycline, as determined by one-way
ANOVA followed by a Tukey’s multiple comparisons test (P< 0.05).
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cells compared with the d2EGFP-UTR162–174-expressing
cells while basal levels of d2EGFP were similar
(Figure 6C–E). Consistent with the data presented in
Figure 3, the stable d2EGFP-UTR162–174 reporter
mRNA was retained primarily in the nucleus, whereas
the expression of this mRNA decreased in the polysomal
fraction within 4 h. Taken together, all of the heterologous
reporter mRNAs containing the U-rich region from the
30UTR of DDB2 (UTR1–343, UTR150–198 and
UTR175–194) exhibited accelerated d2EGFP mRNA
induction, mRNA export and mRNA decay, whereas
the stable vector control and d2EGFP-UTR162–174
mRNAs were induced more slowly and tended to be
retained in the nucleus (recall Figures 1–6). Our results
indicate that the 30UTR of DDB2 contains cis-acting
elements that profoundly inﬂuence gene expression
through a combination of transcriptional and post-tran-
scriptional mechanisms.
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2 days to inhibit reporter gene expression (+Dox). Doxycycline was
washed out, and the cells were replaced with fresh medium for the
indicated time. (A) Cells were collected and analysed by ﬂow cytometry.
Similar results were obtained in three independent experiments. (B) The
recovery of green ﬂuorescence from experiments in (A) are expressed as
a percentage of the untreated control. (C) Total cellular RNA was
collected from similarly treated cells and the recovery of d2EGFP
mRNA expression is presented. Each value in (B) and (C) represents
the mean (±SEM) from three independent experiments. The curves in
B and C were signiﬁcantly different by two-way ANOVA (P< 0.0001).
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Figure 5. Inducible expression of d2EGFP. Stable HEK293 Tet-On
-derived cells expressing the indicated reporter constructs were treated
with a 1mg/ml doxycycline to induce reporter gene expression. (A) Cells
were collected at the indicated for ﬂow cytometric analysis. Similar
results were obtained in three independent experiments. (B) The mean
increase in green ﬂorescence at each time point, determined from ex-
periments in (A), is presented. (C) The results in (B) are also presented
as a percentage of ﬂuorescence detected by 24 h. Each value in (B) and
(C) represents the mean (±SEM) from three independent experiments.
The curves in panels (B) and (C) were signiﬁcantly different by two-way
ANOVA (P< 0.0001).
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DISCUSSION
The 30UTR of DDB2 contains a novel cis-acting
determinant of mRNA stability
The abundance of any given transcript is a function of its
rates of both production and turnover. It has become clear
that although transcription plays a dominant role in
determining the expression of mRNAs, transcriptional
regulation is insufﬁcient to fully explain RNA abundance
(35). The half-lives of mRNAs are often highly conserved
and transcripts encoding functionally related proteins
show coordinated changes in mRNA stability, indicating
that this level of gene regulation contributes to gene
expression (36–38). Therefore, although transcription
has historically been the focus of efforts to understand
the regulation of gene expression, mRNA decay has
emerged as another important level of regulation
(36,39–42).
The mRNA decay machinery receives instruction from
cis-acting elements that are typically located in the 30UTR
of targeted transcripts. The best characterized
elements are adenylate-uridylate-rich elements (ARE)
and guanidylate-uridylate-rich elements (43–47).
Transacting RNA-binding proteins bind these elements
and direct transcripts for decay through de-adenylation
followed by exosome-mediated decay (30–50) and/or
50decapping with subsequent Xrn1-dependent
exonucleolytic degradation (50–30) (45,46). These
destabilizing elements, when inserted into the 30UTR of
otherwise stable reporter mRNA, accelerate decay of
heterologous mRNAs (48,49). These reporter systems
provide a straight forward way to characterize sequences
that target speciﬁc mRNAs for accelerated decay (48,49).
Here, we used this strategy to localize a functional
destabilizing element to a 25-nt region that contained a
13-nt U-rich sequence that when deleted prevented the
accelerated decay of the heterologous reporter mRNA.
BlastN analysis was performed using the 25-nt sequence
corresponding to nucleotides 150–174 from the 30UTR of
DDB2 to query the human RNA sequence database
(RefSeq RNA at http://blast.ncbi.nlm.nih.gov/) (50).
Four additional transcripts (ZNF493, SS18, MAK and
Figure 6. A short U-rich sequence in the 30UTR of DDB2 regulates the induction, export and decay of the reporter mRNA (A) Synthetic 30UTRs
corresponding to nucleotide 150–198 with deletions of the inverted repeat (175–194) and U-rich rich regions (162–174) were used to generate
additional heterologous reporter constructs. The inverted repeats are shaded, and the U-rich region is italicized for clarity. (B) Stable pools of
d2EGFP-positive cells and transiently transfected HeLa Tet-Off cells were exposed to 1 mg/ml doxycycline, and d2EGFP expression was monitored
by qRT-PCR. (C) The indicated stable cell lines were collected, and green ﬂuorescence was quantitatively determined by ﬂow cytometry. (D and E)
The expression of d2EGFP was blocked with a low concentration of doxycycline then washed out to permit re-expression of d2EGFP, as described
in Figure 4. The recovery of green ﬂuorescence (D) and d2EGFP mRNA (E) is expressed as the percentage of their respective no doxycycline
controls. (F) The remaining d2EGFP mRNA in the indicated pool of RNA 4h following the addition of doxycycline is presented. Each value
represents the mean (±SEM) from several independent experiments. In (B), (D) and (E), the asterisk and double asterisk indicate the UTR175–194
curve is signiﬁcantly different from the UTR 162–174, as determined by two-way ANOVA at P< 0.05 and P< 0.0001, respectively. In (F), the
asterisk indicates the residual expression of d2EGFP mRNA following doxycycline treatment is signiﬁcantly different in UTR175–194 compared with
UTR175–194 cells, as determined by student t-test (P< 0.05).
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XPNPEP3) were identiﬁed that contained highly similar
sequences that were all localized to 30UTRs in the sense
orientation (Supplementary Table S3). No similarity to
either coding or antisense UTR sequences was identiﬁed
through this approach, strongly suggesting that these
sequences represent a novel cis-acting element. Through
a survey of other 30UTRs studied in our laboratories, we
also identiﬁed a similar sequence in the sense orientation
in the 30UTR of baculoviral inhibitor of apoptosis (IAP)
repeat containing 2 (BIRC2) mRNA (Supplementary
Table S3). This sequence had previously been cloned
into a chloramphenicol acetyltransferase (CAT) 30UTR
reporter vector and destabilized the reporter mRNA
(51). Taken together, the 30UTR of DDB2 contains a
short U-rich sequence that is capable of destabilizing
heterologous RNAs, and this element appears to be
present and may be similarly functional in other 30UTRs.
The 30UTR of DDB2 affects the distribution of
heterologous reporter mRNAs
Conceptually similar reporter constructs have been
generated from the same pTRE-d2EGFP vector to study
the role of 30UTRs from p16(INK4a) and MKP1 on
mRNA decay (48,49). One of the beneﬁts of this system
that had yet to be used is the fact that the d2EGFP protein
is short-lived owing to the presence of a proteasome-tar-
geting sequence at its C-terminus (32). Therefore,
d2EGFP protein and mRNA expression were expected
to correlate in this model system. Consistent with this ra-
tionale, insertion of the 30UTR of IL-1b containing an
ARE (52) led to decreased protein expression
(Supplementary Figure S2). In contrast, the 30UTR of
DDB2 unexpectedly increased basal d2EGFP protein
levels, consistent with increased translation from the
heterologous d2EGFP-UTR1–343 mRNA. To study the
fraction of d2EGFP mRNA immediately available for
translation, ribosome-associated RNA was isolated. The
amount of polysome-associated RNA correlated much
better than total mRNA with d2EGFP protein levels.
Meanwhile, the stable d2EGFP mRNAs (vector control
and d2EGFP-UTR162–174) were detected in the nuclear
fraction, whereas the unstable heterologous mRNAs
(UTR1–343, UTR150–198 and UTR175–194) were depleted
equally well from all fractions. Therefore, the bulk of
the stable d2EGFP messages were in the nucleus and un-
available for translation. The most parsimonious explan-
ation is the 30UTR of DDB2 facilitates both nuclear
export and cytoplasmic decay of the heterologous
reporter mRNAs.
The 30UTR of DDB2 and inducible gene expression
Comparing nascent transcription to RNA abundance
suggests that changes in gene expression cannot be
explained by changes in transcription rate alone, and
that changes in mRNA stability are integral to regulation
of gene expression (35,53,54). Genome-wide analysis of
mRNA decay indicates that transcripts encoding house-
keeping proteins, metabolic enzymes and structural
proteins tend to have longer half-lives, whereas those
encoding transcription factors, cell signaling proteins
and cell cycle regulators tend to be short-lived
(36,39–42). Short-lived mRNAs tend to be transcription-
ally responsive, whereas the longer-lived transcripts are
typically constitutively expressed (36,39–42). Metabolic
labelling experiments in bacterial lipopolysaccharide-
treated dendritic cells indicate that mRNA abundance
was predominantly determined by NFkB-dependent tran-
scription, whereas changes in mRNA stability permitted
transcripts to reach new equilibrium levels and subse-
quently recover faster, giving rise to a ‘peaked’ response
(55). Our own analysis of the p53 response indicated that
most p53-responsive mRNAs, including DDB2, were
labile and exhibited a similar peaked response (29).
Taken together, mRNA decay appears to have a
pronounced effect on shaping expression patterns with
short-lived mRNAs exhibiting rapid peaked responses
and long-lived mRNAs exhibiting slower and compara-
tively sustained responses (55,56).
Recent evidence in Saccharomyces cerevisiae suggests a
direct and causal relationship between transcription and
mRNA decay (57–59). The fate of mRNA in the cyto-
plasm is determined, in part, through promoter sequences
(57–59). It is thought that the binding of speciﬁc
transcription factors to promoter elements affects the co-
transcriptional assembly of the mRNA ribonucleoprotein
complex, leaving a lasting mark on the nascent transcript
that directs it to a particular fate (60). The Rbp4/7
heterodimer and Ccr4-Not complex represent two
examples of factors that associate with nascent transcripts
and link transcription, mRNA export and mRNA decay
(59–63). The term ‘synthegradase’ has been coined to
describe the contribution of proteins to the synthesis and
decay of mRNAs (64).
Reporter genes have been powerful tools to study gene
induction and mRNA decay, but these processes have
usually been studied independently. Here, we developed
heterologous reporter constructs under control of a tetra-
cycline-regulated promoter that permitted us to monitor
both the induction and decay of transcripts uniquely dif-
fering in 30UTR sequences. Heterologous reporter con-
structs containing the 30UTR of DDB2, or portions of
this 30UTR, were capable of impacting the synthesis,
subcellular localization and decay of the reporter
mRNAs. These multiple effects were entirely unexpected
and provided strong evidence that transcription, nuclear
export and cytoplasmic decay are also tightly coupled in
human cells. Although the precise mechanism remains to
be deﬁned, it is plausible that these sequences identiﬁed in
the 30UTR of DDB2 are recognized co-transcriptionally
such that the mRNA ribonucleoprotein complex differs
among reporter mRNAs. Whether the orthologous
Rbp4/7 and/or Ccr4-Not complexes are involved in
determining the fate of these mRNAs is still a matter of
speculation.
Opposing effects of the 30UTR on mRNA stability and
protein expression
Heterologous reporter constructs containing the 30UTR of
DDB2 expressed higher steady state levels and permitted
more rapid induction of d2EGFP expression. Similarly,
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the 30UTR of BIRC2 was able to destabilize a separate
reporter mRNA (CAT) while positively inﬂuencing CAT
protein expression (Supplementary Figure S3). Therefore,
two distinct heterologous mRNAs (CAT and D2EGFP)
exhibited a similar inverse relationship between mRNA
stability and protein expression when the 30UTRs of
BIRC2 and DDB2, containing similar sequences in their
30UTRs were present. This was not typical of unstable
reporter mRNAs in either reporter system. For example,
the presence of 30UTRs with ARE sequences (TNFa and
IL1b) decreased mRNA and protein levels concordantly
(Supplementary Figures S2 and S3). Taken together, the
30UTR of DDB2 contains a previously uncharacterized
cis-acting element that confers mRNA instability but
increased protein expression. This element appears to be
present in the sense orientation in other 30UTRs
(Supplementary Table S3), and thus it may be similarly
involved in regulating the expression of these mRNAs and
proteins.
In summary, nucleotides 150–174 derived from the
30UTR of DDB2 function confer a variety of interesting
features on heterologous 30UTR reporter mRNAs. The
mRNAs containing this sequence were unstable, but
these unstable transcripts were induced better than a
variety of mRNAs lacking this sequence. The positive
effect on gene expression was associated with increase
induction, nuclear export and protein expression. This
synthetic 30UTR facilitated shut-off of the same reporter
gene, suggesting that the modiﬁed vector represents a sig-
niﬁcant improvement over current commercially available
tetracycline-regulated expression vectors and likely other
vectors as well. Not only does the present work provide
novel insight into DDB2 regulation but the positive inﬂu-
ence of this sequence on reporter gene expression may
facilitate conditional expression of transgenes in experi-
mental models and may even have uses in gene therapy.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–3 and Supplementary Figures
1–3.
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